Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Marsh

Showing results (481-490 of 654) with videos related to

Pageof 66
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1991
The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancerJ C Marsh, J R Bertino, K H Katz, et al.
Transplantation|January 27, 1996
A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantationR W Gruessner, G W Burke, R Stratta, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2004
Synthesis of 1H-pyridin-2-one derivatives as potent and selective farnesyltransferase inhibitorsLe Wang, Nan-Horng Lin, Qun Li, et al.
Journal of the American Society of Nephrology : JASN|August 3, 2013
Soluble CR1 therapy improves complement regulation in C3 glomerulopathyYuzhou Zhang, Carla M Nester, Danniele G Holanda, et al.
Transplantation|February 1, 1994
The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenograftsS K Pruitt, A D Kirk, R R Bollinger, et al.
Journal of Immunological Methods|September 15, 1993
Characterization of monoclonal antibodies specific for the V beta 3 family of the human T cell receptor generated using soluble TCR beta-chainS D Calaman, G R Carson, L D Henry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Phase I clinical and pharmacological studies of benzylacyclouridine, a uridine phosphorylase inhibitorG Pizzorno, L Yee, B A Burtness, et al.
Neuropsychiatric Disease and Treatment|November 28, 2014
Evaluation of clinical and inflammatory profile in opioid addiction patients with comorbid pain: results from a multicenter investigationBrittany B Dennis, M Constantine Samaan, Monica Bawor, et al.
Journal of Medicinal Chemistry|October 29, 2000
Discovery of novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intracellular adhesion molecule-1 interaction. 1. Identification of an additional binding pocket based on an anilino diaryl sulfide leadG Liu, J T Link, Z Pei, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 1999
Potent piperazine hydroxyethylamine HIV protease inhibitors containing novel P3 ligandsX Chen, D J Kempf, H L Sham, et al.
Pageof 66

Showing results (481-490 of 654) with videos related to

Sort By:
Pageof 66
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1991
The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancerJ C Marsh, J R Bertino, K H Katz, et al.
Transplantation|January 27, 1996
A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantationR W Gruessner, G W Burke, R Stratta, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2004
Synthesis of 1H-pyridin-2-one derivatives as potent and selective farnesyltransferase inhibitorsLe Wang, Nan-Horng Lin, Qun Li, et al.
Journal of the American Society of Nephrology : JASN|August 3, 2013
Soluble CR1 therapy improves complement regulation in C3 glomerulopathyYuzhou Zhang, Carla M Nester, Danniele G Holanda, et al.
Transplantation|February 1, 1994
The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenograftsS K Pruitt, A D Kirk, R R Bollinger, et al.
Journal of Immunological Methods|September 15, 1993
Characterization of monoclonal antibodies specific for the V beta 3 family of the human T cell receptor generated using soluble TCR beta-chainS D Calaman, G R Carson, L D Henry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Phase I clinical and pharmacological studies of benzylacyclouridine, a uridine phosphorylase inhibitorG Pizzorno, L Yee, B A Burtness, et al.
Neuropsychiatric Disease and Treatment|November 28, 2014
Evaluation of clinical and inflammatory profile in opioid addiction patients with comorbid pain: results from a multicenter investigationBrittany B Dennis, M Constantine Samaan, Monica Bawor, et al.
Journal of Medicinal Chemistry|October 29, 2000
Discovery of novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intracellular adhesion molecule-1 interaction. 1. Identification of an additional binding pocket based on an anilino diaryl sulfide leadG Liu, J T Link, Z Pei, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 1999
Potent piperazine hydroxyethylamine HIV protease inhibitors containing novel P3 ligandsX Chen, D J Kempf, H L Sham, et al.
Pageof 66